A. Hatzizacharias

473 total citations
16 papers, 373 citations indexed

About

A. Hatzizacharias is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, A. Hatzizacharias has authored 16 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Physiology. Recurrent topics in A. Hatzizacharias's work include Blood Pressure and Hypertension Studies (6 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Hormonal Regulation and Hypertension (3 papers). A. Hatzizacharias is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Hormonal Regulation and Hypertension (3 papers). A. Hatzizacharias collaborates with scholars based in Greece and United States. A. Hatzizacharias's co-authors include P. Krespi, Michael Kyriakidis, Thomas Makris, V. Votteas, George Stavroulakis, Argyri Gialeraki, Filippos Triposkiadis, T. Makris, Maria V. Poulakou and Despina Perrea and has published in prestigious journals such as American Heart Journal, American Journal of Hypertension and International Journal of Cardiology.

In The Last Decade

A. Hatzizacharias

16 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Hatzizacharias Greece 10 216 100 83 59 52 16 373
P. Krespi Greece 10 245 1.1× 101 1.0× 83 1.0× 58 1.0× 50 1.0× 16 401
Sona Haku Japan 13 182 0.8× 101 1.0× 48 0.6× 59 1.0× 18 0.3× 25 366
Giovanni Cerasola Italy 15 370 1.7× 191 1.9× 95 1.1× 72 1.2× 15 0.3× 32 739
Anna Vadalà Italy 14 240 1.1× 45 0.5× 64 0.8× 80 1.4× 13 0.3× 17 478
Ryu Kobayashi Japan 15 227 1.1× 162 1.6× 66 0.8× 72 1.2× 19 0.4× 42 521
Ch. Schnack Austria 14 200 0.9× 154 1.5× 52 0.6× 65 1.1× 12 0.2× 20 500
Tomohiro Asahi Japan 9 212 1.0× 120 1.2× 239 2.9× 131 2.2× 29 0.6× 12 456
Mariapina Pomilio Italy 10 138 0.6× 147 1.5× 68 0.8× 107 1.8× 10 0.2× 11 567
Changan Yu China 14 118 0.5× 51 0.5× 106 1.3× 71 1.2× 31 0.6× 32 487
Lina Zhao China 15 129 0.6× 109 1.1× 129 1.6× 163 2.8× 35 0.7× 24 563

Countries citing papers authored by A. Hatzizacharias

Since Specialization
Citations

This map shows the geographic impact of A. Hatzizacharias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Hatzizacharias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Hatzizacharias more than expected).

Fields of papers citing papers by A. Hatzizacharias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Hatzizacharias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Hatzizacharias. The network helps show where A. Hatzizacharias may publish in the future.

Co-authorship network of co-authors of A. Hatzizacharias

This figure shows the co-authorship network connecting the top 25 collaborators of A. Hatzizacharias. A scholar is included among the top collaborators of A. Hatzizacharias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Hatzizacharias. A. Hatzizacharias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Papadopoulos, Dimitrios, et al.. (2006). Antiendothelial Cell Antibody Levels in Healthy Normotensives with High Normal Blood Pressure. Clinical and Experimental Hypertension. 28(8). 663–667. 8 indexed citations
2.
Papadopoulos, Dimitris, et al.. (2006). Human Soluble Leptin Receptor Concentration in Healthy Offspring of Hypertensive Parents. Journal of Clinical Hypertension. 8(11). 797–802. 4 indexed citations
3.
Makris, Thomas, et al.. (2006). White coat hypertension and haemostatic/fibrinolytic balance disorders.. PubMed. 17(2). 137–41. 7 indexed citations
4.
Papadopoulos, Dimitrios, Thomas Makris, P. Krespi, et al.. (2005). Adiponectin and Resistin Plasma Levels in Healthy Individuals With Prehypertension. Journal of Clinical Hypertension. 7(12). 729–733. 33 indexed citations
5.
Papadopoulos, Dimitris, P. Krespi, Maria V. Poulakou, et al.. (2005). Human Soluble Leptin Receptor Number in Healthy Normotensive Individuals With High Normal Blood Pressure. American Journal of Hypertension. 18(7). 1001–1004. 8 indexed citations
6.
Papadopoulos, Dimitrios, Thomas Makris, P. Krespi, et al.. (2005). Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure.. PubMed. 16(3). 211–4. 9 indexed citations
7.
Krespi, P., et al.. (2004). Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.. PubMed. 30(3). 125–32. 21 indexed citations
8.
Paizis, Ioannis, P. Krespi, Ourania Papazachou, et al.. (2004). Insulin receptor number is reduced in healthy offspring of patients with essential hypertension. American Journal of Hypertension. 17(10). 911–914. 6 indexed citations
9.
Makris, Thomas, et al.. (2003). Markers of risk in young offspring with paternal history of myocardial infarction. International Journal of Cardiology. 89(2-3). 287–293. 12 indexed citations
10.
Makris, Thomas, George Stavroulakis, A. Hatzizacharias, et al.. (2003). Parental history of hypertension is associated with coagulation–fibrinolytic balance disorders. Thrombosis Research. 111(1-2). 45–49. 7 indexed citations
11.
Makris, T., P. Krespi, A. Hatzizacharias, et al.. (2000). Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol. American Journal of Hypertension. 13(7). 783–788. 71 indexed citations
12.
Stavroulakis, George, Thomas Makris, P. Krespi, et al.. (2000). Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism. Cardiovascular Drugs and Therapy. 14(4). 427–432. 65 indexed citations
13.
Makris, Thomas, George Stavroulakis, Urania Dafni, et al.. (2000). ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. American Heart Journal. 140(5). 760–765. 22 indexed citations
14.
Makris, Thomas, George Stavroulakis, P. Krespi, et al.. (1999). Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. American Heart Journal. 138(5). 922–925. 32 indexed citations
15.
Krespi, P., et al.. (1998). Moxonidine Effect on Microalbuminuria, Thrombomodulin, and Plasminogen Activator Inhibitor-1 Levels in Patients with Essential Hypertension. Cardiovascular Drugs and Therapy. 12(5). 463–467. 37 indexed citations
16.
Makris, Thomas, P. Krespi, A. Hatzizacharias, et al.. (1997). HAEMOSTASIS BALANCE DISORDERS IN PATIENTS WITH ESSENTIAL HYPERTENSION. Thrombosis Research. 88(2). 99–107. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026